(Q34514088)

2 August 2017

1 reference

title

Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification (English)

1 reference

2 August 2017

1 reference

Ian F Pollack

1

1 reference

2 August 2017

Jaclyn Biegel

2

1 reference

2 August 2017

Allan Yates

3

1 reference

2 August 2017

Ronald Hamilton

4

1 reference

2 August 2017

Sydney Finkelstein

5

1 reference

2 August 2017

publication date

1 March 2002

1 reference

2 August 2017

published in

Current Oncology Reports

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

114-122

1 reference

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

2 August 2017

cites work

1 reference

12 December 2020

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

12 December 2020

Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor

1 reference

12 December 2020

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

12 December 2020

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1 reference

12 December 2020

Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood

1 reference

12 December 2020

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

12 December 2020

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study

1 reference

12 December 2020

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

1 reference

12 December 2020

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

12 December 2020

Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.

1 reference

12 December 2020

Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

1 reference

12 December 2020

A molecular genetic model of astrocytoma histopathology

1 reference

12 December 2020

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

1 reference

12 December 2020

Monosomy 22 in rhabdoid or atypical tumors of the brain

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

1 reference

12 December 2020

Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.

1 reference

12 December 2020

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

12 December 2020

Proliferation index as a predictor of prognosis in malignant gliomas of childhood

1 reference

12 December 2020

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

1 reference

12 December 2020

The lack of a role for p53 in astrocytomas in pediatric patients

1 reference

12 December 2020

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

1 reference

12 December 2020

Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.

1 reference

12 December 2020

Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.

1 reference

12 December 2020

Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.

1 reference

12 December 2020

Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children.

1 reference

12 December 2020

Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study

1 reference

12 December 2020

Serial analysis of gene expression

1 reference

12 December 2020

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

12 December 2020

The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors

1 reference

12 December 2020

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

12 December 2020

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

1 reference

12 December 2020

Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.

1 reference

12 December 2020

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort

1 reference

12 December 2020

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

1 reference

12 December 2020

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

1 reference

12 December 2020

Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience

1 reference

12 December 2020

Brain tumors in children

1 reference

12 December 2020

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

1 reference

12 December 2020

Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.

1 reference

12 December 2020

High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis

1 reference

12 December 2020

Expression of p53 and prognosis in children with malignant gliomas.

1 reference

12 December 2020

Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study

1 reference

12 December 2020

The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.

1 reference

12 December 2020

10.1007/S11912-002-0072-5

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1012068297

0 references

1 reference